Skip to main content

IGC Pharma, Inc.

IGC
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001326205

No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.43M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +3 vs. previous quarter
36
13F valueReported value at the end of Q2 2026
$1.43M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding IGC, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding IGC at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by IGC Pharma, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 27, 2024 (view filing)4:05 PM ETSep 252 daysMoran James PDirectorPPurchase+588.2K$0.34+$200.0K+166.1%942.4K after

Top 10 13F holders, Q2 2026

The largest institutional positions in IGC Pharma, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 36 holders
Institutions holding IGC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Geode Capital Management, LLC879,394$239.2K0.00%−163,990−15.7%Reduced
Vanguard Capital Management LLC814,914$221.7K0.00%+96,478+13.4%Added
BlackRock, Inc.703,798$191.4K0.00%00.0%Unchanged
AdvisorShares Investments LLC678,480$184.5K0.02%+678,480New
Citadel Advisors LLC437,317$119.0K0.00%+437,317New
Vanguard Fiduciary Trust Co419,413$114.1K0.00%+3,525+0.8%Added
Renaissance Technologies LLC286,608$78.0K0.00%−197,367−40.8%Reduced
State Street Corp200,799$54.6K0.00%00.0%Unchanged
Northern Trust Corp170,274$46.3K0.00%+56,867+50.1%Added
Dearborn Partners LLC118,802$31.8K0.00%+59,401+100.0%Added